​

Inspire Medical Systems (INSP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INSP Stock Forecast

Inspire Medical Systems (INSP) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $170.00, with a high of $230.00 and a low of $125.00. This represents a 115.82% increase from the last price of $78.77.

$50 $90 $130 $170 $210 $250 High: $230 Avg: $170 Low: $125 Last Closed Price: $78.77

INSP Stock Rating

Inspire Medical Systems stock's rating consensus is Buy, based on 25 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (64.00%), 9 Hold (36.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 25 0 9 16 Strong Sell Sell Hold Buy Strong Buy

INSP Price Target Upside V Benchmarks

TypeNameUpside
StockInspire Medical Systems115.82%
SectorHealthcare Stocks 13.55%
IndustryMedical Device Stocks16.49%

Price Target Trends

1M3M12M
# Anlaysts1611
Avg Price Target$150.00$157.50$192.00
Last Closing Price$78.77$78.77$78.77
Upside/Downside90.43%99.95%143.75%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25368--17
Aug, 25485--17
Jul, 25585--18
Jun, 25585--18
May, 25585--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 02, 2025Daniel MarkowitzEvercore ISI$150.00$94.5158.71%90.43%
Aug 05, 2025Piper Sandler$150.00$87.9170.63%90.43%
Aug 05, 2025Lake Street$150.00$87.9170.63%90.43%
Aug 05, 2025Danielle AntalffyUBS$230.00$87.91161.63%191.99%
Aug 05, 2025Stifel Nicolaus$140.00$87.9159.25%77.73%
Aug 05, 2025Truist Financial$125.00$87.9142.19%58.69%
May 06, 2025Kallum TitchmarshMorgan Stanley$200.00$161.8823.55%153.90%
Apr 15, 2025Shagun SinghRBC Capital$215.00$146.2447.02%172.95%
Nov 05, 2024Adam MaederPiper Sandler$260.00$199.0030.65%230.07%
Nov 05, 2024David RescottRobert W. Baird$252.00$199.0026.63%219.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2025Evercore ISIOutperforminitialise
Aug 05, 2025UBSBuyBuyhold
Aug 05, 2025KeyBancSector Weightdowngrade
May 06, 2025Morgan StanleyOverweightOverweighthold
Apr 15, 2025RBC CapitalOutperformOutperformhold
Nov 20, 2024Bank of America SecuritiesNeutralBuyupgrade
Sep 30, 2024Truist FinancialMarket PerformMarket Performhold
Sep 10, 2024RBC CapitalMarket PerformMarket Performhold
Jul 29, 2024JefferiesBuyBuyhold
Jul 15, 2024Morgan StanleyOverweightOverweighthold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.19$-1.54$-1.60$-0.72$1.80----
Avg Forecast$-2.40$-1.89$-2.29$-1.29$1.34$1.97$3.21$4.15$5.66
High Forecast$-2.31$-1.82$-2.26$-1.08$1.43$2.51$3.79$4.25$5.69
Low Forecast$-2.45$-1.93$-2.32$-1.62$1.28$1.68$2.86$3.98$5.62
Surprise %-8.75%-18.52%-30.13%-44.19%34.33%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$115.38M$233.39M$407.86M$624.80M$802.80M----
Avg Forecast$111.30M$229.61M$401.02M$619.50M$799.62M$949.63M$1.12B$1.31B$1.53B
High Forecast$112.86M$232.81M$405.36M$619.55M$802.83M$952.32M$1.12B$1.31B$1.53B
Low Forecast$108.06M$222.91M$396.31M$619.48M$795.90M$945.71M$1.12B$1.31B$1.52B
Surprise %3.66%1.65%1.70%0.86%0.40%----

Net Income Forecast

$-100M $-40M $20M $80M $140M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-57.20M$-42.04M$-44.88M$-21.15M$53.51M----
Avg Forecast$-64.27M$-51.71M$-59.56M$-21.15M$39.71M$59.68M$92.64M$116.87M$165.97M
High Forecast$-51.42M$-41.37M$-47.65M$-16.92M$42.03M$73.68M$111.15M$124.43M$166.77M
Low Forecast$-77.13M$-62.05M$-71.47M$-25.38M$37.39M$49.22M$83.92M$116.59M$164.54M
Surprise %-11.00%-18.69%-24.64%-34.76%----

INSP Forecast FAQ

Is Inspire Medical Systems stock a buy?

Inspire Medical Systems stock has a consensus rating of Buy, based on 25 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Inspire Medical Systems is a favorable investment for most analysts.

What is Inspire Medical Systems's price target?

Inspire Medical Systems's price target, set by 25 Wall Street analysts, averages $170 over the next 12 months. The price target range spans from $125 at the low end to $230 at the high end, suggesting a potential 115.82% change from the previous closing price of $78.77.

How does Inspire Medical Systems stock forecast compare to its benchmarks?

Inspire Medical Systems's stock forecast shows a 115.82% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the medical device stocks industry (16.49%).

What is the breakdown of analyst ratings for Inspire Medical Systems over the past three months?

  • September 2025: 17.65% Strong Buy, 35.29% Buy, 47.06% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 23.53% Strong Buy, 47.06% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 27.78% Strong Buy, 44.44% Buy, 27.78% Hold, 0% Sell, 0% Strong Sell.

What is Inspire Medical Systems’s EPS forecast?

Inspire Medical Systems's average annual EPS forecast for its fiscal year ending in December 2025 is $1.97, marking a 9.44% increase from the reported $1.8 in 2024. Estimates for the following years are $3.21 in 2026, $4.15 in 2027, and $5.66 in 2028.

What is Inspire Medical Systems’s revenue forecast?

Inspire Medical Systems's average annual revenue forecast for its fiscal year ending in December 2025 is $949.63M, reflecting a 18.29% increase from the reported $802.8M in 2024. The forecast for 2026 is $1.12B, followed by $1.31B for 2027, and $1.53B for 2028.

What is Inspire Medical Systems’s net income forecast?

Inspire Medical Systems's net income forecast for the fiscal year ending in December 2025 stands at $59.68M, representing an 11.53% increase from the reported $53.51M in 2024. Projections indicate $92.64M in 2026, $116.87M in 2027, and $165.97M in 2028.